Bayhill Therapeutics and the Juvenile Diabetes Research Foundation Announce Research Collaboration for the Clinical Development of a Novel Immunotherapeutic DNA Vaccine for Type 1 Diabetes

Download Formats

• Thumbnail
  GIF, 120x37, 1.4 KB
• Preview
  JPEG, 144x45, 1.8 KB
• Low Resolution
  JPEG, 864x270, 13.6 KB
• High Resolution
  JPEG, 864x270, 38.3 KB

Share This Logo